Shkreli Pleads Not Guilty to Hiding Retrophin HoldingsBy
Company founder, ex-lawyer Greebel face new conspiracy charge
Former drug company CEO accused of masking control of stock
Former drug company executive Martin Shkreli pleaded not guilty to a conspiracy charge accusing him of using employees and consultants to conceal his control of Retrophin Inc. stock.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.